Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT - ASSETS

3 Months Ended

Mar. 31, 2022

NOTE 4 — SELECTED FINANCIAL STATEMENT - ASSETS

Inventories consisted of the following (in thousands):

	March 31, 2022			December 31, 2021
Raw materials and components	$	1,477		$	1,439
Work-in-process		132			115
Finished goods		6,028			6,228
Inventory reserve		(4,184	)		(3,390	)
Total	$	3,453		$	4,392

Prepaid expenses and other current assets consisted of the following (in thousands):

Property and equipment consisted of the following (in thousands):

	March 31, 2022			December 31, 2021
Equipment	$	344		$	342
Leasehold improvements		39			39
Furniture and fixtures		103			103
Construction-in-progress		57			57
Total property and equipment		543			541
Less: accumulated depreciation		(405	)		(394	)
Property and equipment, net	$	138		$	147

During each of the three months ended March 31, 2022 and 2021, depreciation expenses were approximately $11,000.